Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma
European Journal of Cancer2005Vol. 41(17), pp. 2769–2778
Citations Over TimeTop 10% of 2005 papers
Martin G. Friedrich, Shahin Chandrasoma, Kimberly D. Siegmund, Daniel J. Weisenberger, Jonathan Cheng, Marieta Toma, Hartwig Huland, Peter A. Jones, Gangning Liang
Related Papers
- → p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a(2007)268 cited
- → CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Patients(2011)73 cited
- Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.(2001)
- → Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes(2012)18 cited
- → Depicting the role of CDKN2A/ARF alterations in adult BCR-ABL1-positive acute lymphoblastic leukemia patients: from genomic deletions to prognostic impact(2011)